ArticlebioRxiv : the preprint server for biology2025
Insights into the Absence of Lymphoma Despite Fulminant Epstein-Barr Virus Infection in Patients with XIAP Deficiency.
Yizhe Sun, Janet Chou, Kevin Dong, Steven P Gygi, Benjamin E Gewurz
Abstract readPreprint
In one paragraphArticle in bioRxiv : the preprint server for biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
5 · Who and what moneyAuthors and funding
5 authors.
Yizhe SunDivision of Infectious Diseases, Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts, United States of America.
Janet ChouDivision of Immunology, Department of Pediatrics Harvard Medical School, Boston Children's Hospital, Boston, Massachusetts, USA.
Kevin DongDepartment of Cell Biology, Harvard Medical School, Boston, Massachusetts, United States.
Steven P GygiDepartment of Cell Biology, Harvard Medical School, Boston, Massachusetts, United States.
Benjamin E GewurzDivision of Infectious Diseases, Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts, United States of America.
Funding
Targeting the Epigenetic and Metabolic Control of EBV-Epithelial CancersP01CA269043 · NCI · WISTAR INSTITUTE · PI Italo Tempera · 2023 to 2026
$12.0MB cell determinants of EBV latency (supplement)U01CA275301 · NCI · WEILL MEDICAL COLL OF CORNELL UNIV · PI Ethel Cesarman, Benjamin Elison Gewurz · 2022 to 2026
$4.0MEpstein-Barr virus LMP1 mediated oncogenicityR01CA228700 · NCI · BRIGHAM AND WOMEN'S HOSPITAL · PI Benjamin Elison Gewurz · 2019 to 2026
$3.3MRegulation of the Epstein-Barr Virus Lytic SwitchR01AI164709 · NIAID · BRIGHAM AND WOMEN'S HOSPITAL · PI Benjamin Elison Gewurz · 2021 to 2026
$3.1MEpstein-Barr Virus Driven Tonsillar Versus Peripheral B-cell One-Carbon Metabolic Network RemodelingR01DE033907 · NIDCR · BRIGHAM AND WOMEN'S HOSPITAL · PI Benjamin Elison Gewurz · 2024 to 2026
$1.5MSystematic CRISPR Analysis of EBV Lymphoma Resistance Pathways to Natural Killer Cell LysisR21AI181873 · NIAID · BRIGHAM AND WOMEN'S HOSPITAL · PI GEWURZ, BENJAMIN ELISON · 2024 to 2025
$492kCharacterization of Epstein-Barr Virus Subversion of the Host SMC5/6 Restriction PathwayR21AI170751 · NIAID · BRIGHAM AND WOMEN'S HOSPITAL · PI GEWURZ, BENJAMIN ELISON · 2023 to 2024
$492kNCI NIH HHS P01 CA269043NCI NIH HHS R01 CA228700NCI NIH HHS U01 CA275301NIAID NIH HHS R01 AI164709NIAID NIH HHS R21 AI170751NIAID NIH HHS R21 AI181873NIDCR NIH HHS R01 DE033907
6 · The paper itselfAbstract
X-linked Lymphoproliferative Syndromes (XLP), which arise from mutations in the
Identifiers
PMID39868266
PMCPMC11761029
What OpenQuestion holds
Textmetadata
LicenceCC BY-ND
Read underepoch 390